Johnson & Johnson (JNJ) Non-cash Items (2010 - 2012)
Johnson & Johnson's (JNJ) quarterly Non-cash Items came in at $1.0 billion in Q1 2012, up 54.94% year-on-year from $648.0 million in Q1 2011, and up 54.94% quarter-over-quarter from $648.0 million in Q1 2011.
Johnson & Johnson (JNJ) Non-cash Items (2010 - 2012) Analysis & Trends
Johnson & Johnson has disclosed Non-cash Items across 3 years of filings, most recently posting $1.0 billion for Q1 2012.
- Non-cash Items for Q1 2012 came in at $1.0 billion, up 54.94% year-over-year; the trailing twelve-month figure through Jan 2012 was $1.0 billion (up 54.94% YoY), and the FY2012 annual result was $1.0 billion, up 54.94% from the prior year.
- Non-cash Items came in at $1.0 billion for Q1 2012 at Johnson & Johnson, up from $648.0 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $1.0 billion in Q1 2012 to a low of $148349.0 in Q1 2010.
- The 3-year median for Non-cash Items is $648.0 million (2011), against an average of $550.7 million.
- Across the five-year window, Non-cash Items soared 436707.8% in 2011 and soared 54.94% in 2012, its largest moves.
- Johnson & Johnson's Non-cash Items stood at $148349.0 in 2010, then jumped by 436707.8% to $648.0 million in 2011, then jumped by 54.94% to $1.0 billion in 2012.
- The last three Non-cash Items figures came in at $1.0 billion (Q1 2012), $648.0 million (Q1 2011), and $148349.0 (Q1 2010), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 1, 2012 | 1.00 Bn |
| Jan 1, 2012 | 1.00 Bn |
| Jan 2, 2011 | 648.00 Mn |
| Jan 2, 2011 | 648.00 Mn |
| Jan 3, 2010 | 148,349.00 |
| Jan 3, 2010 | 148,349.00 |